SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Columbia University Scientists Sniff Out Prion Secret
December 22, 2008
 · 
1 min read
Drug Development
Long-term Memory Disrupted Genetically In Fruit Flies; Drug Found To Help Them Regain Memories, University of Alberta Study
December 19, 2008
 · 
1 min read
Drug Development
Fatal Attraction: How Leukemia Seduces Blood Cells, University of Chicago Study
December 19, 2008
 · 
1 min read
Drug Development
Manipulating Key Protein May Prevent Eczema, Children’s Hospital Boston/Harvard Medical School Study
December 18, 2008
 · 
1 min read
Drug Development
HIV Can Penetrate a Woman’s Healthy Genital Skin, Northwestern University Study
December 17, 2008
 · 
1 min read
Drug Development
Small Doses of Carbon Monoxide Might Help Stroke Victims, Johns Hopkins University Researchers Report
December 17, 2008
 · 
1 min read
Drug Development
Cellular Stress Causes Fatty Liver Disease In Mice, University of Iowa And University of Michigan Study
December 16, 2008
 · 
1 min read
Drug Development
Promising New Drug Blocks Mutation In Bone Marrow Cancers, Oregon Health & Science University (OHSU) Study
December 15, 2008
 · 
1 min read
Drug Development
Preventing A Broken Heart: Research Aims To Reduce Scarring From Heart Attacks, University of Wisconsin-Madison And Cornell University Study
December 15, 2008
 · 
1 min read
Drug Development
Experts At East China Normal University And University of California, San Francisco (UCSF) And Boost Learning In Rats With Hearing Defects
December 15, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
CMG901 for the treatment of gastric cancer and gastroesophageal junction adenocarcinoma was granted the Orphan-drug Designation by the Food and Drug Administration of the United States
April 12, 2022
 · 
2 min read
Drug Development
NANOBOTIX: New Preclinical Immunotherapy Data Show Boosted Anti-Tumor Immune Activation via Triple Blockade of PD-1, LAG-3, and TIGIT When Combined With Radiotherapy-Activated NBTXR3
April 11, 2022
 · 
9 min read
Drug Development
Actinium Pharmaceuticals Highlights Potent Anti-Tumor Activity of a HER3 Targeted Radiotherapy at AACR
April 11, 2022
 · 
6 min read
Drug Development
Vivace Therapeutics Presents New Preclinical Data Highlighting Strong Synergistic Activity for Combination of VT3989 and Osimertinib at American Association for Cancer Research (AACR) Annual Meeting 2022
April 11, 2022
 · 
3 min read
Drug Development
Beyond Cancer™ Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect
April 11, 2022
 · 
9 min read
Drug Development
SQZ Biotechnologies Presents New eAPC Preclinical Data Demonstrating That Multiplexed mRNA Engineering of Immune Cells Increases Killer T Cell Activity In Vivo
April 11, 2022
 · 
10 min read
Drug Development
Seneca Therapeutics, Inc. Presents Promising New Preclinical Data Combining its Lead Oncolytic Immunotherapeutic SVV-001 in Combination with Checkpoint Inhibitors at the 2022 Annual AACR Meeting
April 11, 2022
 · 
2 min read
Drug Development
InnoCare Presents Pre-Clinical Data of ICP-723 at AACR Annual Meeting 2022
April 11, 2022
 · 
2 min read
Drug Development
Triumvira Immunologics to Present Two Posters Covering Ongoing Phase 1/2 Solid Tumor Trial and New Preclinical Gastric Cancer Data at AACR Annual Meeting 2022
April 10, 2022
 · 
4 min read
Drug Development
PIC Therapeutics to Present Pre-Clinical Data on eIF4E Program to Address Breast Cancer Drug Resistance at AACR Annual Meeting 2022
April 9, 2022
 · 
3 min read
Drug Development
Shattuck Labs Presents Preclinical Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting
April 8, 2022
 · 
4 min read
Drug Development
Cellectis Presents Preclinical Data from its First Allogeneic Dual CAR T-cell Product Candidate UCART20x22 for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma at the American Association for Cancer Research (AACR) 2022 Annual Meeting
April 8, 2022
 · 
6 min read
Drug Development
Preclinical Immunotherapy Research Featured in Poster Presentation at AACR 2022 Annual Meeting Highlights YIV-906’s Immunomodulatory Mechanisms in Combination with Immune Checkpoint or CAR T Therapy
April 8, 2022
 · 
3 min read
Drug Development
2seventy bio Presents New Preclinical Data on bbT369, an Investigational Dual-Targeting Gene-Edited CAR T Cell Therapy, at the AACR Annual Meeting
April 8, 2022
 · 
8 min read
Drug Development
HotSpot Therapeutics Presents Pre-Clinical Data on CBL-B Program at American Association for Cancer Research Annual Meeting 2022
April 8, 2022
 · 
3 min read
Drug Development
Repare Therapeutics to Present New Clinical and Preclinical Data at the 2022 AACR Annual Meeting
April 8, 2022
 · 
7 min read
Drug Development
Xencor Presents Data from Multiple Preclinical XmAb® Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022
April 8, 2022
 · 
6 min read
Drug Development
Sonnet BioTherapeutics Announces Preclinical Data Supporting Its Bispecific Interleukin Candidates at the American Association for Cancer Research (AACR) 2022 Annual Meeting
April 8, 2022
 · 
4 min read
Drug Development
Asher Bio to Unveil Two New Immunotherapy Programs, a CD8+ T Cell Targeted IL-21 and a Cis-Targeted IL-2 for Cell Therapy Augmentation, at AACR Annual Meeting
April 8, 2022
 · 
8 min read
Drug Development
Catamaran Bio Presents Preclinical In Vivo Efficacy Data Supporting Advancement of CAT‑179, a HER2-targeted Allogeneic CAR-NK Cell Therapy
April 8, 2022
 · 
3 min read
Load More